MEDLAB CLINICAL LIMITED - Announcements

Market Cap $15.07M Add to my watchlist

Healthcare Biotechnology

Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company focused on... Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company focused on the development and commercialization of a pharmaceutical delivery platform. The Company is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas, including pain management, mental health, gut health, diabetes, and allergies. The Company’s drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The Company's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress . The Company also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) is stepping up its trial activities in Australia’s nearest Asian neighbour, Indonesia. Recce’s flagship anti-infective, R327, can be applied as a gel – and this gel-based version of the drug has been of specific interest...

Announcements

Filter Results

All Price Sensitive Only

MDC	Becoming a substantial holder from MS		28/03/18	424.55KB	Share
MDC	S&P DJ Indices Announces March Quarterly Rebalance	PRICE SENSITIVE	09/03/18	201.26KB	Share
MDC	Medlab's Progress to Date on Cannabis Spray (NanaBis)	PRICE SENSITIVE	02/03/18	485.74KB	Share
MDC	Appendix 4D	PRICE SENSITIVE	28/02/18	225.14KB	Share
MDC	Half Year Accounts		28/02/18	590.03KB	Share
MDC	Change in substantial holding		05/02/18	119.34KB	Share
MDC	Change in substantial holding		05/02/18	385.14KB	Share
MDC	Change in substantial holding		05/02/18	534.1KB	Share
MDC	Appendix 3B and Notice under Section 708(5)(e)		01/02/18	1.43MB	Share
MDC	Medlab Permitted to Sell or Supply Cannabis in QLD and ACT	PRICE SENSITIVE	01/02/18	471KB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/18	338.06KB	Share
MDC	Successful Completion of a Heavily Over-Subscribed Placement	PRICE SENSITIVE	25/01/18	1.31MB	Share
MDC	Trading Halt	PRICE SENSITIVE	23/01/18	1.55MB	Share
MDC	Medlab Granted Licences-Sell or Supply Cannabis in Australia	PRICE SENSITIVE	10/01/18	326.28KB	Share
MDC	MDC's Cannabis (CBD/THC) Product expected Late Feb 18	PRICE SENSITIVE	23/11/17	869.69KB	Share
MDC	Change in substantial holding		16/11/17	87.21KB	Share
MDC	Change of Director's Interest Notice		16/11/17	86.32KB	Share
MDC	Appendix 3B		16/11/17	109.8KB	Share
MDC	Results of Meeting		10/11/17	1.31MB	Share
MDC	AGM Presentation 2017		10/11/17	8.9MB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/17	337.22KB	Share
MDC	MDC Completes First Medical Cannabis Oil (CBD/THC) Shipment	PRICE SENSITIVE	24/10/17	358.75KB	Share
MDC	Notice of Annual General Meeting/Proxy Form		09/10/17	752.29KB	Share
MDC	Medlab's Anti-Depression Product Granted 20 Year AU Patent	PRICE SENSITIVE	18/09/17	315.67KB	Share
MDC	Corporate Governance Statement 2017		31/08/17	115.8KB	Share
MDC	Appendix 4G		31/08/17	198.07KB	Share
MDC	Annual Report to shareholders		31/08/17	8.47MB	Share
MDC	Appendix 4E	PRICE SENSITIVE	31/08/17	40.24KB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/17	1.01MB	Share
MDC	Appendix 3B - Shares out of Escrow		21/07/17	130.96KB	Share
MDC	Medlab and Heritage Brands Join Forces to Market Products	PRICE SENSITIVE	13/07/17	58.19KB	Share
MDC	Release of Shares and Options from Escrow		29/06/17	1.31MB	Share
MDC	Medlab Granted Ethics Approval for Two Cannabis Trials	PRICE SENSITIVE	19/06/17	192.2KB	Share
MDC	Corporate Governance Statement		16/05/17	115.78KB	Share
MDC	Response to ASX Query	PRICE SENSITIVE	05/05/17	1.71MB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/17	1.04MB	Share
MDC	Letter to Shareholders		10/04/17	1.97MB	Share
MDC	Investor Presentation		30/03/17	18.32MB	Share
MDC	MEDLAB GRANTED ETHICS APPROVAL FOR PHASE 2A DEPRESSION STUDY	PRICE SENSITIVE	27/03/17	308.63KB	Share
MDC	Medlab Signs Agreement to Start Comparison Study for Statins	PRICE SENSITIVE	06/03/17	297.32KB	Share
MDC	December 2016 Financial Report		28/02/17	3.6MB	Share
MDC	Shareholder Letter		28/02/17	374.53KB	Share
MDC	Appendix 4D	PRICE SENSITIVE	28/02/17	62.47KB	Share
MDC	Government Easing of Cannabis Supply as Medlab Trial Nears	PRICE SENSITIVE	22/02/17	296.37KB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/17	957.77KB	Share
MDC	Breakthrough for Medlab - TGA Grants Licence for Cannabis	PRICE SENSITIVE	10/11/16	298.73KB	Share
MDC	Media Release - Medlab Prepares to Start Cannabis Trial	PRICE SENSITIVE	07/11/16	300.32KB	Share
MDC	Results of Meeting		04/11/16	1.31MB	Share
MDC	AGM 2016 - Presentation		04/11/16	9.91MB	Share
MDC	Appendix 4C - quarterly-MDC.AX	PRICE SENSITIVE	31/10/16	1.04MB	Share
MDC	Notice of Annual General Meeting/Proxy Form-MDC.AX		05/10/16	1MB	Share
MDC	Change of Director's Interest Notice-MDC.AX		02/09/16	88.22KB	Share
MDC	Annual Report to shareholders-MDC.AX		31/08/16	6.91MB	Share
MDC	Appendix 4G-MDC.AX		31/08/16	211.71KB	Share
MDC	Preliminary Final Report-MDC.AX	PRICE SENSITIVE	31/08/16	33.92KB	Share
MDC	Rights Issue - Issue of Shortfall Shares-MDC.AX		30/08/16	292.72KB	Share
MDC	Medlab Heading to Phase 2A with Anti-Depression Therapy-MDC.AX	PRICE SENSITIVE	30/08/16	300.31KB	Share
MDC	Medlab & Aphria Complete Cannabis Supply Agreement-MDC.AX	PRICE SENSITIVE	22/08/16	332.1KB	Share
MDC	Change of Director's Interest Notice x 2-MDC.AX		17/08/16	175.34KB	Share
MDC	Change in substantial holding-MDC.AX		17/08/16	128.27KB	Share
MDC	Top 20 security holders - Updated-MDC.AX		16/08/16	44.04KB	Share
MDC	Appendix 3B-MDC.AX		16/08/16	179.94KB	Share
MDC	Completion of Rights Issue-MDC.AX		16/08/16	293.14KB	Share
MDC	Renounceable Issue - Notification of Shortfall-MDC.AX		15/08/16	295.13KB	Share
MDC	Medlab Supports the Legalisation of Cannabis in NSW-MDC.AX		01/08/16	312.24KB	Share
MDC	Appendix 4C - quarterly-MDC.AX	PRICE SENSITIVE	29/07/16	1.4MB	Share
MDC	Notice of Dispatch of Offer Document-MDC.AX		25/07/16	293.46KB	Share
MDC	Notice to Ineligible Shareholders-MDC.AX		19/07/16	220.97KB	Share
MDC	Notice to Shareholders-MDC.AX		19/07/16	162.27KB	Share
MDC	Appendix 3B - Rights Issue-MDC.AX		18/07/16	191.81KB	Share
MDC	Renounceable Issue-MDC.AX		18/07/16	306.57KB	Share
MDC	Renounceable Issue-MDC.AX		18/07/16	265.06KB	Share
MDC	Renounceable Issue-MDC.AX	PRICE SENSITIVE	18/07/16	330.27KB	Share
MDC	Response to ASX Appendix 4C Query-MDC.AX	PRICE SENSITIVE	23/05/16	1.7MB	Share
MDC	Letter to Shareholders-MDC.AX		23/05/16	2.52MB	Share
MDC	Response to ASX Price Query-MDC.AX	PRICE SENSITIVE	20/05/16	1.69MB	Share
MDC	Trading Halt-MDC.AX	PRICE SENSITIVE	20/05/16	248.23KB	Share
MDC	Appendix 4C - quarterly-MDC.AX	PRICE SENSITIVE	28/04/16	110.88KB	Share
MDC	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	11/02/16	3.93MB	Share
MDC	Medlab Supports New Federal Legislation for Medical Cannabis		11/02/16	53.1KB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/16	110.64KB	Share
MDC	Letter to Shareholders		29/01/16	1.91MB	Share
MDC	Appendix 3B		02/11/15	112.46KB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/15	109.83KB	Share
MDC	Change in substantial holding		27/10/15	121.73KB	Share
MDC	Results of Meeting		26/10/15	1.31MB	Share
MDC	AGM 2015 - Shareholder Update		26/10/15	1.34MB	Share
MDC	Appendix 3B - Shares out of Escrow		23/10/15	135.38KB	Share
MDC	Supplementary Notice of 2015 AGM		24/09/15	1.32MB	Share
MDC	Notice of Annual General Meeting/Proxy Form		23/09/15	1.14MB	Share
MDC	Shares coming out of Escrow		21/09/15	1.31MB	Share
MDC	Appendix 3B - Shares out of Escrow		21/09/15	135.64KB	Share
MDC	Appendix 3B - Shares out of Escrow		28/08/15	135.2KB	Share
MDC	Appendix 4G		27/08/15	230.57KB	Share
MDC	Annual Report to shareholders		27/08/15	6.39MB	Share
MDC	Appendix 4E	PRICE SENSITIVE	27/08/15	31.96KB	Share
MDC	Release of Restricted Shares from Escrow		21/08/15	1.35MB	Share
MDC	Release of Restricted Shares from Escrow		31/07/15	1.35MB	Share
MDC	Letter to Shareholders		31/07/15	1.49MB	Share
MDC	Media Release - Medlab Granted Cannabis Research Licence		29/07/15	67.22KB	Share

MDC Becoming a substantial holder from MS
28/03/18		424.55KB	Share
MDC S&P DJ Indices Announces March Quarterly Rebalance
09/03/18	PRICE SENSITIVE	201.26KB	Share
MDC Medlab's Progress to Date on Cannabis Spray (NanaBis)
02/03/18	PRICE SENSITIVE	485.74KB	Share
MDC Appendix 4D
28/02/18	PRICE SENSITIVE	225.14KB	Share
MDC Half Year Accounts
28/02/18		590.03KB	Share
MDC Change in substantial holding
05/02/18		119.34KB	Share
MDC Change in substantial holding
05/02/18		385.14KB	Share
MDC Change in substantial holding
05/02/18		534.1KB	Share
MDC Appendix 3B and Notice under Section 708(5)(e)
01/02/18		1.43MB	Share
MDC Medlab Permitted to Sell or Supply Cannabis in QLD and ACT
01/02/18	PRICE SENSITIVE	471KB	Share
MDC Appendix 4C - quarterly
31/01/18	PRICE SENSITIVE	338.06KB	Share
MDC Successful Completion of a Heavily Over-Subscribed Placement
25/01/18	PRICE SENSITIVE	1.31MB	Share
MDC Trading Halt
23/01/18	PRICE SENSITIVE	1.55MB	Share
MDC Medlab Granted Licences-Sell or Supply Cannabis in Australia
10/01/18	PRICE SENSITIVE	326.28KB	Share
MDC MDC's Cannabis (CBD/THC) Product expected Late Feb 18
23/11/17	PRICE SENSITIVE	869.69KB	Share
MDC Change in substantial holding
16/11/17		87.21KB	Share
MDC Change of Director's Interest Notice
16/11/17		86.32KB	Share
MDC Appendix 3B
16/11/17		109.8KB	Share
MDC Results of Meeting
10/11/17		1.31MB	Share
MDC AGM Presentation 2017
10/11/17		8.9MB	Share
MDC Appendix 4C - quarterly
31/10/17	PRICE SENSITIVE	337.22KB	Share
MDC MDC Completes First Medical Cannabis Oil (CBD/THC) Shipment
24/10/17	PRICE SENSITIVE	358.75KB	Share
MDC Notice of Annual General Meeting/Proxy Form
09/10/17		752.29KB	Share
MDC Medlab's Anti-Depression Product Granted 20 Year AU Patent
18/09/17	PRICE SENSITIVE	315.67KB	Share
MDC Corporate Governance Statement 2017
31/08/17		115.8KB	Share
MDC Appendix 4G
31/08/17		198.07KB	Share
MDC Annual Report to shareholders
31/08/17		8.47MB	Share
MDC Appendix 4E
31/08/17	PRICE SENSITIVE	40.24KB	Share
MDC Appendix 4C - quarterly
31/07/17	PRICE SENSITIVE	1.01MB	Share
MDC Appendix 3B - Shares out of Escrow
21/07/17		130.96KB	Share
MDC Medlab and Heritage Brands Join Forces to Market Products
13/07/17	PRICE SENSITIVE	58.19KB	Share
MDC Release of Shares and Options from Escrow
29/06/17		1.31MB	Share
MDC Medlab Granted Ethics Approval for Two Cannabis Trials
19/06/17	PRICE SENSITIVE	192.2KB	Share
MDC Corporate Governance Statement
16/05/17		115.78KB	Share
MDC Response to ASX Query
05/05/17	PRICE SENSITIVE	1.71MB	Share
MDC Appendix 4C - quarterly
28/04/17	PRICE SENSITIVE	1.04MB	Share
MDC Letter to Shareholders
10/04/17		1.97MB	Share
MDC Investor Presentation
30/03/17		18.32MB	Share
MDC MEDLAB GRANTED ETHICS APPROVAL FOR PHASE 2A DEPRESSION STUDY
27/03/17	PRICE SENSITIVE	308.63KB	Share
MDC Medlab Signs Agreement to Start Comparison Study for Statins
06/03/17	PRICE SENSITIVE	297.32KB	Share
MDC December 2016 Financial Report
28/02/17		3.6MB	Share
MDC Shareholder Letter
28/02/17		374.53KB	Share
MDC Appendix 4D
28/02/17	PRICE SENSITIVE	62.47KB	Share
MDC Government Easing of Cannabis Supply as Medlab Trial Nears
22/02/17	PRICE SENSITIVE	296.37KB	Share
MDC Appendix 4C - quarterly
31/01/17	PRICE SENSITIVE	957.77KB	Share
MDC Breakthrough for Medlab - TGA Grants Licence for Cannabis
10/11/16	PRICE SENSITIVE	298.73KB	Share
MDC Media Release - Medlab Prepares to Start Cannabis Trial
07/11/16	PRICE SENSITIVE	300.32KB	Share
MDC Results of Meeting
04/11/16		1.31MB	Share
MDC AGM 2016 - Presentation
04/11/16		9.91MB	Share
MDC Appendix 4C - quarterly-MDC.AX
31/10/16	PRICE SENSITIVE	1.04MB	Share
MDC Notice of Annual General Meeting/Proxy Form-MDC.AX
05/10/16		1MB	Share
MDC Change of Director's Interest Notice-MDC.AX
02/09/16		88.22KB	Share
MDC Annual Report to shareholders-MDC.AX
31/08/16		6.91MB	Share
MDC Appendix 4G-MDC.AX
31/08/16		211.71KB	Share
MDC Preliminary Final Report-MDC.AX
31/08/16	PRICE SENSITIVE	33.92KB	Share
MDC Rights Issue - Issue of Shortfall Shares-MDC.AX
30/08/16		292.72KB	Share
MDC Medlab Heading to Phase 2A with Anti-Depression Therapy-MDC.AX
30/08/16	PRICE SENSITIVE	300.31KB	Share
MDC Medlab & Aphria Complete Cannabis Supply Agreement-MDC.AX
22/08/16	PRICE SENSITIVE	332.1KB	Share
MDC Change of Director's Interest Notice x 2-MDC.AX
17/08/16		175.34KB	Share
MDC Change in substantial holding-MDC.AX
17/08/16		128.27KB	Share
MDC Top 20 security holders - Updated-MDC.AX
16/08/16		44.04KB	Share
MDC Appendix 3B-MDC.AX
16/08/16		179.94KB	Share
MDC Completion of Rights Issue-MDC.AX
16/08/16		293.14KB	Share
MDC Renounceable Issue - Notification of Shortfall-MDC.AX
15/08/16		295.13KB	Share
MDC Medlab Supports the Legalisation of Cannabis in NSW-MDC.AX
01/08/16		312.24KB	Share
MDC Appendix 4C - quarterly-MDC.AX
29/07/16	PRICE SENSITIVE	1.4MB	Share
MDC Notice of Dispatch of Offer Document-MDC.AX
25/07/16		293.46KB	Share
MDC Notice to Ineligible Shareholders-MDC.AX
19/07/16		220.97KB	Share
MDC Notice to Shareholders-MDC.AX
19/07/16		162.27KB	Share
MDC Appendix 3B - Rights Issue-MDC.AX
18/07/16		191.81KB	Share
MDC Renounceable Issue-MDC.AX
18/07/16		306.57KB	Share
MDC Renounceable Issue-MDC.AX
18/07/16		265.06KB	Share
MDC Renounceable Issue-MDC.AX
18/07/16	PRICE SENSITIVE	330.27KB	Share
MDC Response to ASX Appendix 4C Query-MDC.AX
23/05/16	PRICE SENSITIVE	1.7MB	Share
MDC Letter to Shareholders-MDC.AX
23/05/16		2.52MB	Share
MDC Response to ASX Price Query-MDC.AX
20/05/16	PRICE SENSITIVE	1.69MB	Share
MDC Trading Halt-MDC.AX
20/05/16	PRICE SENSITIVE	248.23KB	Share
MDC Appendix 4C - quarterly-MDC.AX
28/04/16	PRICE SENSITIVE	110.88KB	Share
MDC Appendix 4D and Half Year Accounts
11/02/16	PRICE SENSITIVE	3.93MB	Share
MDC Medlab Supports New Federal Legislation for Medical Cannabis
11/02/16		53.1KB	Share
MDC Appendix 4C - quarterly
29/01/16	PRICE SENSITIVE	110.64KB	Share
MDC Letter to Shareholders
29/01/16		1.91MB	Share
MDC Appendix 3B
02/11/15		112.46KB	Share
MDC Appendix 4C - quarterly
29/10/15	PRICE SENSITIVE	109.83KB	Share
MDC Change in substantial holding
27/10/15		121.73KB	Share
MDC Results of Meeting
26/10/15		1.31MB	Share
MDC AGM 2015 - Shareholder Update
26/10/15		1.34MB	Share
MDC Appendix 3B - Shares out of Escrow
23/10/15		135.38KB	Share
MDC Supplementary Notice of 2015 AGM
24/09/15		1.32MB	Share
MDC Notice of Annual General Meeting/Proxy Form
23/09/15		1.14MB	Share
MDC Shares coming out of Escrow
21/09/15		1.31MB	Share
MDC Appendix 3B - Shares out of Escrow
21/09/15		135.64KB	Share
MDC Appendix 3B - Shares out of Escrow
28/08/15		135.2KB	Share
MDC Appendix 4G
27/08/15		230.57KB	Share
MDC Annual Report to shareholders
27/08/15		6.39MB	Share
MDC Appendix 4E
27/08/15	PRICE SENSITIVE	31.96KB	Share
MDC Release of Restricted Shares from Escrow
21/08/15		1.35MB	Share
MDC Release of Restricted Shares from Escrow
31/07/15		1.35MB	Share
MDC Letter to Shareholders
31/07/15		1.49MB	Share
MDC Media Release - Medlab Granted Cannabis Research Licence
29/07/15		67.22KB	Share

REFRESH

First 2 3 4

(20min delay)
Last $6.60		Change 0.000(0.00%)		Mkt cap ! $15.07M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

MDC (ASX) Chart

Day chart unavailable

MEDLAB CLINICAL LIMITED - Announcements

Announcements

Top Stories